Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription 04.08.2025 3 Am Heart J 2 Am J Cardiol 2 Angiology 1 Ann Intern Med 3 Ann Thorac Surg 2 BMJ 2 Cardiovasc Res 4 Circ Cardiovasc Interv 1 Circ Genom Precis Med 1 Circ Res 2 Circulation 2 Clin Cardiol 1 Clin Chem 2 Eur Heart J 1 Heart 6 Int J Cardiol 4 J Thorac Cardiovasc Surg 1 JAMA 6 Lancet 1 PLoS One 2 Prog Cardiovasc Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. REINSTADLER SJ, Kronbichler A, Reindl M, Tiller C, et al
   Selective C-reactive protein apheresis in ST-elevation myocardial infarction: Design and rationale of the randomized CRP-STEMI trial.
   Am Heart J. 2025 Jul 28:S0002-8703(25)00283-2. doi: 10.1016/j.ahj.2025.
   PubMed         Abstract available
   
   
2. HANIF M, Khan LA, Kulkarni A, Bhatia HS, et al
   Global lipoprotein (a) testing trends from 2015 to 2023.
   Am Heart J. 2025 Jun 21:S0002-8703(25)00199-1. doi: 10.1016/j.ahj.2025.
   PubMed         Abstract available
   
   
3. SWOBODA PP, Berry C, McCann GP, Kelion A, et al
   Design and rationale of "a pragmatic approach to the investigation of stable chest pain: A UK, multicenter, randomized trial to assess patient outcomes, quality of life and cost effectiveness (CE-MARC 3)".
   Am Heart J. 2025;289:95-104.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

4. O'NEAL WT, Acharya G, Wallace S, Prescott M, et al
   Impact of CCTA/FFR(CT) on Referrals for Invasive Coronary Angiography and Revascularization in a Community-Based Healthy System.
   Am J Cardiol. 2025 Jul 25:S0002-9149(25)00426.
   PubMed        
   
   
5. SHANAB BM, Bunn DA, Oseran AS, Wadhera RK, et al
   Insurance Coverage & Plan Choice Complexity for Medicare Beneficiaries with Cardiovascular Disease.
   Am J Cardiol. 2025 Jul 23:S0002-9149(25)00422.
   PubMed         Abstract available
   
   

   
   Angiology

6. CETINER MA, Vorpahl M, Seyfarth M, Wiederhold U, et al
   A Comparison of Carotid Ultrasound and Coronary Optical Coherence Tomography in Assessing Plaque Morphology in Patients with Chronic Coronary Syndrome.
   Angiology. 2025 Jul 30:33197251355336. doi: 10.1177/00033197251355336.
   PubMed         Abstract available
   
   
7. STERPETTI AV, Miceli F, Di Girolamo A, Iannone I, et al
   Cardiovascular Oncology: Consensus Statements Are Still Lacking to Improve the Management of Side-Effects of Old and New Chemotherapeutic Agents.
   Angiology. 2025 Jul 29:33197251356583. doi: 10.1177/00033197251356583.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

8. AGGARWAL R, Wadhera RK, Chiu N, Szarek M, et al
   Cardiovascular Risk Factor and Disease Mortality Among Asian Indian, Chinese, and Filipino Adults in the United States, 2018 to 2023.
   Ann Intern Med. 2025 Jul 29. doi: 10.7326/ANNALS-25-00108.
   PubMed        
   
   

   
   Ann Thorac Surg

9. GRANT MC, Kanwar MK, Spelde AE, Chatterjee S, et al
   Temporary Mechanical Circulatory Support in Cardiogenic Shock: Executive Summary of the Joint Consensus Reports of the PeriOperative Quality Initiative and the Enhanced Recovery After Surgery Cardiac Society.
   Ann Thorac Surg. 2025;120:194-201.
   PubMed         Abstract available
   
   
10. GRANT MC, Brudney CS, Hernandez-Montfort J, Ibekwe SO, et al
    Definitions of Cardiogenic Shock and Indications for Temporary Mechanical Circulatory Support: Joint Consensus Report of the PeriOperative Quality Initiative and the Enhanced Recovery After Surgery Cardiac Society.
    Ann Thorac Surg. 2025;120:202-212.
    PubMed         Abstract available
    
    
11. SPELDE AE, Barron LM, Cangut B, Hickey GW, et al
    Escalation and De-escalation of Temporary Mechanical Circulatory Support: Joint Consensus Report of the PeriOperative Quality Initiative and the Enhanced Recovery After Surgery Cardiac Society.
    Ann Thorac Surg. 2025;120:213-224.
    PubMed         Abstract available
    
    

    
    BMJ

12. TAYAL U
    Sex differences in antithrombotic therapy for coronary artery disease.
    BMJ. 2025;390:r1560.
    PubMed        
    
    
13. PICCOLO R, Laino A, Vitale AP, Franzone A, et al
    Sex related differences in efficacy and safety of antithrombotic therapy in patients with coronary artery disease: systematic review and meta-analysis.
    BMJ. 2025;390:e082974.
    PubMed         Abstract available
    
    

    
    Cardiovasc Res

14. LARSSON I, Sun J, Ahmad S, Bergstrom G, et al
    Low-fibre diet is associated with high-risk coronary plaque features.
    Cardiovasc Res. 2025;121:1204-1214.
    PubMed         Abstract available
    
    
15. ABALLO TJ, Bae J, Paltzer WG, Chapman EA, et al
    Integrated proteomics identifies troponin I isoform switch as a regulator of a sarcomere-metabolism axis during cardiac regeneration.
    Cardiovasc Res. 2025;121:1240-1253.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

16. ANG D, Hanna R, Berry C
    Angina After Percutaneous Coronary Intervention?
    Circ Cardiovasc Interv. 2025 Aug 1:e015678.
    PubMed        
    
    
17. BRUCE CG, Halaby RN, Khan JM, Rogers T, et al
    Transcatheter Coronary Artery Bypass to Circumvent Iatrogenic Obstruction: The VECTOR (Ventriculo-Coronary Transcatheter Outward Navigation and Re-Entry) Procedure in Swine.
    Circ Cardiovasc Interv. 2025 Jul 30:e015459.
    PubMed         Abstract available
    
    
18. YAN M, Jiang X
    Letter by Yan and Jiang Regarding Article, "Pressure-Derived Indices in the Left Main Coronary Artery: Insights From Comprehensive In Vivo Hemodynamic Studies of Diseased and Unobstructed Vessels".
    Circ Cardiovasc Interv. 2025 Jul 30:e015736.
    PubMed        
    
    
19. MINCIONE G, Stefanini GG, Paradies V
    Beyond the Valve: Sex-Specific Insights in Aortic Stenosis and Coronary Artery Disease.
    Circ Cardiovasc Interv. 2025 Jul 31:e015565.
    PubMed        
    
    

    
    Circ Genom Precis Med

20. DEGOMA E, Walsh J, Georgakis MK
    Human Genetics Informing Drug Development in Cardiovascular Disease: Interleukin-6 Signaling as a Case Study.
    Circ Genom Precis Med. 2025 Jul 28:e005103. doi: 10.1161/CIRCGEN.125.005103.
    PubMed         Abstract available
    
    

    
    Circ Res

21. TOMBOR LS, Lautenschlager T, Glaser SF, Fischer A, et al
    Immunoregulatory Endothelial Cells Interact With T Cells After Myocardial Infarction.
    Circ Res. 2025 Jul 30. doi: 10.1161/CIRCRESAHA.125.326145.
    PubMed         Abstract available
    
    

    
    Circulation

22. WERESKI R, Morrow DA, Mills NL
    Unstable Angina Refined.
    Circulation. 2025;152:213-216.
    PubMed        
    
    
23. WANG Q, Ismahil MA, Zhu Y, Rokosh G, et al
    CD206(+)IL-4Ralpha(+) Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
    Circulation. 2025;152:257-273.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

24. MEUNIER L, Eccleshall S, Bakdi R, Godin M, et al
    Long-Term Effectiveness of a Stent-Less Strategy With Drug Coated Balloon in Coronary Artery Disease: 3-Year Follow-Up of a Prospective All-Comers Observational Study.
    Clin Cardiol. 2025;48:e70189.
    PubMed         Abstract available
    
    
25. AHMAD E, Ahmad S, Naeem A, Ahmed S, et al
    Trends in Cardiovascular Mortality in Patients With Chronic Kidney Disease From 1999 to 2020: A Retrospective Study in the United States.
    Clin Cardiol. 2025;48:e70174.
    PubMed         Abstract available
    
    

    
    Clin Chem

26. STRANDKJAER N, Hansen MB, Afzal S, Hasselbalch RB, et al
    Influence of Macrotroponin on the 99th Percentile Threshold in 2 High-Sensitivity Cardiac Troponin Assays.
    Clin Chem. 2025;71:884-895.
    PubMed         Abstract available
    
    

    
    Eur Heart J

27. KRALER S, Mueller C, Libby P, Bhatt DL, et al
    Acute coronary syndromes: mechanisms, challenges, and new opportunities.
    Eur Heart J. 2025;46:2866-2889.
    PubMed         Abstract available
    
    
28. 
    Correction to: Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics.
    Eur Heart J. 2025 Jul 31:ehaf579. doi: 10.1093.
    PubMed        
    
    

    
    Heart

29. PARKER WAE
    Evolution of coronary stents: innovations, antithrombotic strategies and future directions.
    Heart. 2025 Mar 4:heartjnl-2024-324744. doi: 10.1136/heartjnl-2024-324744.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

30. HU C
    Cangrelor: A new P2Y12 inhibitor with gender differences.
    Int J Cardiol. 2025;438:133511.
    PubMed         Abstract available
    
    
31. NEBIOLO M, Kang J, Sandrone S, Kim HK, et al
    Duration of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for bifurcation lesions: Insights from the ULTRA-BIFURCAT registry.
    Int J Cardiol. 2025;438:133542.
    PubMed         Abstract available
    
    
32. KATO T, Suzuki K, Kawashima H, Kato Y, et al
    Changes in syndecan-1 concentration in the coronary sinus immediately after cardiac reperfusion reflect postoperative myocardial injury.
    Int J Cardiol. 2025;438:133564.
    PubMed         Abstract available
    
    
33. POLLER A, Jha S, Molander L, Espinosa AS, et al
    Global and segmental longitudinal and radial strain in Takotsubo versus ST-elevation myocardial infarction.
    Int J Cardiol. 2025;439:133668.
    PubMed         Abstract available
    
    
34. DWT N, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up.
    Int J Cardiol. 2025;439:133674.
    PubMed         Abstract available
    
    
35. LIU Y, Li C, Wang L, Hao X, et al
    Report on the adherence to key management strategies and mortality rates in patients with acute myocardial infarction-related cardiogenic shock: Finding from the improving Care for Cardiovascular Disease in China-acute coronary syndrome project.
    Int J Cardiol. 2025 Jul 26:133666. doi: 10.1016/j.ijcard.2025.133666.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

36. AL EBRAHIM KE
    Reassessing outcomes of coronary artery bypass grafting in the presence of chronic total occlusions.
    J Thorac Cardiovasc Surg. 2025 Jul 31:S0022-5223(25)00560.
    PubMed        
    
    
37. PATEL PB, Anyanwu A, Gross CR, Adams DH, et al
    The Intra-Aortic Balloon Pump as a Rescue Device: Do we need to shift our strategy for cardiogenic shock rescue after cardiac surgery?
    J Thorac Cardiovasc Surg. 2024 Sep 24:S0022-5223(24)00836.
    PubMed         Abstract available
    
    
38. ROCHA RV, Yau TM, Chu A, Lee DS, et al
    Do Non-fatal MACCE In The First 5-years Post CABG Affect 10-year Outcomes?
    J Thorac Cardiovasc Surg. 2024 Sep 25:S0022-5223(24)00841.
    PubMed         Abstract available
    
    
39. ALSHNEIKAT M, Awad AK, Bakaeen FG
    Quality of Evidence: Randomized Trials in Coronary Disease and Moving the Goalposts.
    J Thorac Cardiovasc Surg. 2025 Jul 24:S0022-5223(25)00634.
    PubMed        
    
    

    
    JAMA

40. WU J, Kanter GP, Wagner TH, Chu D, et al
    Impact of the MISSION Act on Quality and Outcomes of Major Cardiovascular Procedures Among Veterans.
    JAMA. 2025 Jul 31. doi: 10.1001/jama.2025.11661.
    PubMed         Abstract available
    
    

    
    Lancet

41. RODRIGUEZ-GRANILLO GA, Garcia-Garcia HM, Thierer J
    QFR vs FFR for intermediate coronary stenosis.
    Lancet. 2025;406:333.
    PubMed        
    
    
42. ZHU Q, Cheng Y, Wang S
    QFR vs FFR for intermediate coronary stenosis.
    Lancet. 2025;406:333-334.
    PubMed        
    
    
43. ONUMA Y, Tsai TY, Sharif F, Wykrzykowska J, et al
    QFR vs FFR for intermediate coronary stenosis.
    Lancet. 2025;406:334.
    PubMed        
    
    
44. KOMAMURA K, Miyake H, Kobayashi K, Ishiki R, et al
    QFR vs FFR for intermediate coronary stenosis.
    Lancet. 2025;406:334.
    PubMed        
    
    
45. ANDERSEN BK, Escaned J, Christiansen EH, Holm NR, et al
    QFR vs FFR for intermediate coronary stenosis - Authors' reply.
    Lancet. 2025;406:335-336.
    PubMed        
    
    
46. VRINTS C, Andreotti F
    QFR vs FFR for intermediate coronary stenosis.
    Lancet. 2025;406:335.
    PubMed        
    
    

    
    PLoS One

47. MAMEDOV A, Gecys D, Jakuska P, Treinys R, et al
    How different cardioplegic solutions influence genes expression and cytokine response in an immature rat heart model of ischemia/reperfusion?
    PLoS One. 2025;20:e0329010.
    PubMed         Abstract available
    
    

    
    Prog Cardiovasc Dis

48. GOLUB IS, Misic A, Krishnan S, Hubbard L, et al
    CTA in roadmapping post-CABG evaluation.
    Prog Cardiovasc Dis. 2025;90:86-96.
    PubMed         Abstract available
    
    
49. MALICK WA, Al Dhaybi O, Bhatt DL
    Atherogenic dyslipidemia: A marker of cardiovascular risk in treated hypertension.
    Prog Cardiovasc Dis. 2025 Jul 23:S0033-0620(25)00107.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.